CC1(C)[C@@H]2CC[C@@]1(C)[C@@H]1O[C@@H](O[C@@H](CN)c3cc(Cl)c(OCc4ccccc4)c(OCc4ccccc4)c3)C[C@H]21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?